IL242408B - A continuous multistep step for antibody purification - Google Patents

A continuous multistep step for antibody purification

Info

Publication number
IL242408B
IL242408B IL242408A IL24240815A IL242408B IL 242408 B IL242408 B IL 242408B IL 242408 A IL242408 A IL 242408A IL 24240815 A IL24240815 A IL 24240815A IL 242408 B IL242408 B IL 242408B
Authority
IL
Israel
Prior art keywords
multistep process
purifying antibodies
continuous multistep
continuous
antibodies
Prior art date
Application number
IL242408A
Other languages
English (en)
Hebrew (he)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of IL242408B publication Critical patent/IL242408B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12—Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Sustainable Development (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Water Supply & Treatment (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
IL242408A 2013-05-06 2015-11-02 A continuous multistep step for antibody purification IL242408B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13305593 2013-05-06
PCT/EP2014/059246 WO2014180852A1 (en) 2013-05-06 2014-05-06 Continuous multistep process for purifying antibodies

Publications (1)

Publication Number Publication Date
IL242408B true IL242408B (en) 2020-04-30

Family

ID=48430636

Family Applications (1)

Application Number Title Priority Date Filing Date
IL242408A IL242408B (en) 2013-05-06 2015-11-02 A continuous multistep step for antibody purification

Country Status (19)

Country Link
US (1) US10793622B2 (OSRAM)
EP (2) EP3301115B1 (OSRAM)
JP (2) JP6463734B2 (OSRAM)
KR (1) KR102272851B1 (OSRAM)
CN (2) CN105358572A (OSRAM)
AU (1) AU2014264697B2 (OSRAM)
BR (1) BR112015027812B1 (OSRAM)
CA (1) CA2911462C (OSRAM)
CY (1) CY1125281T1 (OSRAM)
DK (2) DK3301115T3 (OSRAM)
ES (2) ES2905675T3 (OSRAM)
HU (2) HUE038741T2 (OSRAM)
IL (1) IL242408B (OSRAM)
MX (1) MX368177B (OSRAM)
NO (1) NO2994485T3 (OSRAM)
RU (1) RU2662668C2 (OSRAM)
SG (1) SG11201508968XA (OSRAM)
TW (2) TWI675041B (OSRAM)
WO (1) WO2014180852A1 (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
MX379269B (es) * 2012-10-24 2025-03-11 Genzyme Corp Elucion de biomoleculas de resinas multimodales utilizando mes y mops como modificadores de fase movil.
US10519195B2 (en) * 2013-09-17 2019-12-31 Kaneka Corporation Antibody purification method, antibody obtained therefrom, novel antibody purification method using cation exchanger, and antibody obtained therefrom
EP3092049A1 (en) 2014-01-08 2016-11-16 Flodesign Sonics Inc. Acoustophoresis device with dual acoustophoretic chamber
GB201503578D0 (en) * 2015-03-03 2015-04-15 Ge Healthcare Bio Sciences Ab Sanitization method for affinity chromatography matrices
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
EP3015542A1 (de) 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US20170101437A1 (en) * 2015-10-09 2017-04-13 Hetero Drugs Ltd. Process for purification of darbepoetin alfa
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
WO2018051348A1 (en) * 2016-09-14 2018-03-22 Insight Biopharmaceutical Ltd. Methods of purifying and qualifying antibodies
KR20190127655A (ko) 2016-10-19 2019-11-13 프로디자인 소닉스, 인크. 음향학에 의한 친화성 세포 추출
EP3601332A1 (en) * 2017-03-24 2020-02-05 Council of Scientific and Industrial Research A process for the purification of recombinant antibody fragments
GB201711481D0 (en) * 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
KR102286260B1 (ko) * 2017-08-31 2021-08-05 주식회사 녹십자 설파타아제 단백질을 정제하는 방법
JP2021507561A (ja) 2017-12-14 2021-02-22 フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． 音響トランスデューサドライバ及びコントローラ
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
EP3546475A1 (en) 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
KR102337683B1 (ko) * 2018-09-21 2021-12-13 주식회사 녹십자 고효율 항-tfpi 항체 조성물
EP3636657A1 (en) 2018-10-08 2020-04-15 Ablynx N.V. Chromatography-free antibody purification method
WO2020084503A1 (en) * 2018-10-26 2020-04-30 Cadila Healthcare Limited A composition comprising antibody with reduced level of basic variants thereof
WO2020183332A1 (en) * 2019-03-11 2020-09-17 Intas Pharmaceuticals Ltd. Purification of adalimumab using tandem chromatography
WO2020205928A1 (en) * 2019-04-03 2020-10-08 Genzyme Corporation Continuous production of recombinant proteins
CN114026108B (zh) * 2019-06-28 2024-09-10 夏尔巴生物技术(苏州)有限公司 无缝连续流层析方法
AU2020356303A1 (en) * 2019-09-23 2022-04-14 Merck Sharp & Dohme Llc Methods and compositions comprising an anti-CTLA4 monoclonal antibody with reduced host cell proteins and increased polysorbate-80 stability
KR102154952B1 (ko) * 2020-02-21 2020-09-10 프레스티지바이오로직스 주식회사 아달리무맙의 Non-Protein A 정제방법
CN112574321B (zh) * 2020-12-30 2023-10-20 上海赛金生物医药有限公司 一种捕获单克隆抗体-肿瘤坏死因子融合蛋白的亲和纯化方法
WO2022234412A1 (en) 2021-05-03 2022-11-10 Lupin Limited A process for purification of fc-fusion proteins

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121418T1 (de) 1987-10-23 1995-05-15 Schering Corp Verfahren zur proteinreinigung.
JP4057049B2 (ja) 1993-09-21 2008-03-05 ヘモソル インコーポレーテッド 置換クロマトグラフィー法および精製ヘモグロビン産物
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5891741A (en) 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
CN1136317C (zh) 1999-03-12 2004-01-28 中国人民解放军第四军医大学 单克隆抗体双段和单段的制备方法
US20020009445A1 (en) 2000-07-12 2002-01-24 Yansheng Du Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
US6602855B2 (en) 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
CN1504482A (zh) 2002-12-03 2004-06-16 北京优力凯生物技术有限责任公司 无细胞百日咳抗原蛋白的分离纯化方法
PT1745075E (pt) 2004-04-21 2013-06-17 Brigham & Womens Hospital Péptidos de ligação a poli-n-acetilglucosamina (pnag/dpnag) e métodos da sua utilização
ES2612572T3 (es) * 2004-10-21 2017-05-17 Ge Healthcare Bioprocess R&D Ab Matriz de cromatografía
NZ586780A (en) 2005-03-23 2012-02-24 Genmab As Antibodies against CD38 for treatment of multiple myeloma
CN1814775A (zh) 2005-12-06 2006-08-09 中国海洋大学 一种抗病毒活性寡聚肽的制备方法
EP1914242A1 (en) * 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
KR101293504B1 (ko) 2007-07-11 2013-08-07 노보 노르디스크 에이/에스 혼합형 또는 다중형 수지를 사용하는 인자 ｖⅰⅰⅰ의 정제
PT2207568T (pt) 2007-11-16 2017-09-01 Univ Rockefeller Anticorpos específicos para a forma de protofibrilha da proteína beta-amilóide
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
AU2009222115A1 (en) * 2008-02-29 2009-09-11 Biogen Idec Ma Inc. Purified immunoglobulin fusion proteins and methods of their purification
US20110105725A1 (en) * 2008-05-15 2011-05-05 Novo Nordisk A/S Antibody purification process
US20110237781A1 (en) * 2008-07-18 2011-09-29 Talecris Biotherapeutics, Inc. Method of preparing alpha-1 proteinase inhibitor
WO2010071208A1 (ja) 2008-12-19 2010-06-24 武田薬品工業株式会社 抗体の精製方法
WO2010082894A1 (en) 2009-01-13 2010-07-22 Ge Healthcare Bio-Sciences Ab Precipitation of biomolecules with negatively charged polymers
KR101224468B1 (ko) * 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
KR101415660B1 (ko) * 2009-08-07 2014-07-16 이엠디 밀리포어 코포레이션 샘플 중의 1 이상의 불순물로부터 표적 단백질을 정제하는 방법
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
WO2011049798A1 (en) * 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Use of mixed mode chromatography for the capture and purification of basic antibody products
US20130178608A1 (en) * 2009-12-29 2013-07-11 Samir Kulkarni Protein purification by ion exchange
EP2415779B1 (en) 2010-08-02 2015-01-21 ratiopharm GmbH Method of producing and purifying an active soluble sialyltransferase
WO2012125735A1 (en) * 2011-03-15 2012-09-20 Abott Laboratories An integrated approach to the isolation and purification of antibodies
KR102058254B1 (ko) * 2011-03-29 2019-12-20 글락소스미스클라인 엘엘씨 단백질 정제용 완충제 시스템
CA2839542A1 (en) 2011-06-17 2012-12-20 Constitution Medical, Inc. Fixative and staining solutions
US9096648B2 (en) 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
EP2578286A1 (en) * 2011-10-04 2013-04-10 Merck Patent GmbH Method and apparatus for chromatographic purification
US20140302021A1 (en) * 2011-10-25 2014-10-09 Onclave Therapeutics Limited Antibody formulations and methods
WO2013075740A1 (en) * 2011-11-23 2013-05-30 Sanofi Antibody purification method

Also Published As

Publication number Publication date
RU2015151869A (ru) 2017-06-13
CA2911462A1 (en) 2014-11-13
JP2019104735A (ja) 2019-06-27
TW201522363A (zh) 2015-06-16
KR102272851B1 (ko) 2021-07-02
HUE057119T2 (hu) 2022-04-28
EP2994485B1 (en) 2018-01-10
CN116003579A (zh) 2023-04-25
BR112015027812A2 (pt) 2017-07-25
US20160083454A1 (en) 2016-03-24
NO2994485T3 (OSRAM) 2018-06-09
BR112015027812B1 (pt) 2021-03-30
HUE038741T2 (hu) 2018-11-28
JP6463734B2 (ja) 2019-02-06
AU2014264697B2 (en) 2019-08-22
CA2911462C (en) 2021-04-06
SG11201508968XA (en) 2015-11-27
US10793622B2 (en) 2020-10-06
EP2994485A1 (en) 2016-03-16
AU2014264697A1 (en) 2015-11-26
WO2014180852A1 (en) 2014-11-13
DK2994485T3 (en) 2018-04-23
MX368177B (es) 2019-09-23
ES2905675T3 (es) 2022-04-11
CY1125281T1 (el) 2023-06-09
JP2016519137A (ja) 2016-06-30
EP3301115B1 (en) 2021-11-10
CN105358572A (zh) 2016-02-24
EP3301115A1 (en) 2018-04-04
RU2662668C2 (ru) 2018-07-26
ES2665645T3 (es) 2018-04-26
TW201908331A (zh) 2019-03-01
MX2015015482A (es) 2016-03-21
KR20160005047A (ko) 2016-01-13
TWI631132B (zh) 2018-08-01
TWI675041B (zh) 2019-10-21
DK3301115T3 (da) 2022-01-31

Similar Documents

Publication Publication Date Title
IL242408B (en) A continuous multistep step for antibody purification
IL242649A (en) Purification process of monoclonal antibody
PT3004163T (pt) Método para purificação de anticorpo
SG11201603274YA (en) Process for producing methyl methacrylate
IL240753A0 (en) Antibody purification methods
SG11201505204VA (en) Protein purification process
GB201312991D0 (en) Process
IL245805A0 (en) Process for purifying 5,2-dichlorophenol
GB201307334D0 (en) Process
IL239689A0 (en) A method for producing antibodies
SG11201607098SA (en) Antibody purification process
IL241287A0 (en) Processes for the preparation of subfervir
SG11201601819WA (en) Process for separating methacrolein
GB201313915D0 (en) Process
ZA201603797B (en) Novel purification processes
IL243937A (en) A process for the purification of compounds of diaminophenylazinium
GB201307327D0 (en) Process
GB201302441D0 (en) Process
ZA201600424B (en) Purification process for pth
AP2016009185A0 (en) Process for catalyst unloading facilitation
EP2993166A4 (en) PROCESS FOR PURIFYING DIMETHYL SULFOXIDE
HUE051329T2 (hu) Eljárás klór tisztítására frakcionálással
GB201307951D0 (en) Process
GB201300073D0 (en) Process
EP2937141A4 (en) CATALYST COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed